alopecia areata | dermcity

Update: Alopecia areata Tx effective in ages 12 and up

Ritlecitinib is promising for the treatment of adults and adolescents over the age of 12 years with severe alopecia areata, according to...

Higher risk of autoimmune disorders in children of mothers with Alopecia Areata

A new study from Korea has determined that children of mothers with alopecia areata (AA) appear to be at higher risk of developing...

Oral JAK inhibitor treats adolescent alopecia areata

New findings show that the oral Janus kinase (JAK) inhibitor ritlecitinib effectively treats alopecia areata in adolescents. The study...

Methotrexate plus prednisone effective for alopecia Tx

In a recent clinical trial, a combination of methotrexate and low-dose prednisone led to complete hair regrowth (HR) in almost one-third...

Prevalence of pediatric alopecia areata doubles in a decade

A study examining the prevalence and incidence of pediatric alopecia areata (AA) from 2009 to 2020 has determined that prevalence has...

Baricitinib shows promise in alopecia areata

The results of two phase 3 trials of patients with severe alopecia areata (AA) indicate that oral baricitinib was superior to placebo...

it's where dermatology lives